Partek Flow automatically processes and analyzes sequencing data in the background and then passes results to the Agilent Alissa Interpret platform, where the information is combined into a single report, according to the company. The integration is intended to help support clinical decisions and identify genetic disease signatures in the clinical setting.

The agreement allows Agilent to resell Partek Flow software through the Alissa portal for a single-point solution.

Thomas Scientific inks distribution deal with Agilent
Scientific products distributor Thomas Scientific has signed a strategic distribution deal with Agilent Technologies that will allow Thomas to offer a...

Mobilion secures $60M for biologic therapeutic characterization
Mobilion Systems has netted $60 million in a series C financing round.

Agilent debuts its full range of InfinityLab Bio LC products
Agilent Technologies has debuted three InfinityLab Bio liquid chromatography (LC) systems: the 1290 Infinity II Bio LC System with high-speed pump, the...

Agilent reports revenue increase for Q2
Agilent Technologies saw revenue exceed expectations for the company's second quarter, while net income more than doubled.

Agilent offers new flow cytometers
Agilent Technologies has launched a new product offering, the Agilent NovoCyte Penteon, a flow cytometer with five lasers and up to 30 fluorescence channels.